Seek Returns logo

ATR vs. ZTS: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at ATR and ZTS, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolATRZTS
Company NameAptarGroup, Inc.Zoetis Inc.
CountryUnited StatesUnited States
GICS SectorMaterialsHealth Care
GICS IndustryContainers & PackagingPharmaceuticals
Market Capitalization9.30 billion USD69.47 billion USD
ExchangeNYSENYSE
Listing DateApril 23, 1993February 1, 2013
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of ATR and ZTS by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

ATR vs. ZTS: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolATRZTS
5-Day Price Return-1.30%2.42%
13-Week Price Return-11.09%-4.38%
26-Week Price Return-1.49%-4.95%
52-Week Price Return-4.86%-15.03%
Month-to-Date Return-11.17%7.52%
Year-to-Date Return-11.15%-3.79%
10-Day Avg. Volume0.54M2.89M
3-Month Avg. Volume0.39M3.14M
3-Month Volatility26.60%22.66%
Beta0.580.92

Profitability

Return on Equity (TTM)

ATR

15.28%

Containers & Packaging Industry

Max
41.66%
Q3
20.76%
Median
14.35%
Q1
6.55%
Min
3.64%

ATR’s Return on Equity of 15.28% is on par with the norm for the Containers & Packaging industry, indicating its profitability relative to shareholder equity is typical for the sector.

ZTS

53.21%

Pharmaceuticals Industry

Max
38.59%
Q3
19.84%
Median
11.90%
Q1
5.63%
Min
-9.96%

ZTS’s Return on Equity of 53.21% is exceptionally high, placing it well beyond the typical range for the Pharmaceuticals industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

ATR vs. ZTS: A comparison of their Return on Equity (TTM) against their respective Containers & Packaging and Pharmaceuticals industry benchmarks.

Net Profit Margin (TTM)

ATR

10.84%

Containers & Packaging Industry

Max
11.61%
Q3
8.17%
Median
4.91%
Q1
4.20%
Min
0.08%

A Net Profit Margin of 10.84% places ATR in the upper quartile for the Containers & Packaging industry, signifying strong profitability and more effective cost management than most of its peers.

ZTS

27.83%

Pharmaceuticals Industry

Max
34.51%
Q3
17.73%
Median
12.12%
Q1
5.99%
Min
-7.73%

A Net Profit Margin of 27.83% places ZTS in the upper quartile for the Pharmaceuticals industry, signifying strong profitability and more effective cost management than most of its peers.

ATR vs. ZTS: A comparison of their Net Profit Margin (TTM) against their respective Containers & Packaging and Pharmaceuticals industry benchmarks.

Operating Profit Margin (TTM)

ATR

14.30%

Containers & Packaging Industry

Max
22.03%
Q3
13.17%
Median
8.87%
Q1
6.86%
Min
0.07%

An Operating Profit Margin of 14.30% places ATR in the upper quartile for the Containers & Packaging industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

ZTS

35.35%

Pharmaceuticals Industry

Max
41.53%
Q3
23.00%
Median
16.24%
Q1
9.24%
Min
-6.94%

An Operating Profit Margin of 35.35% places ZTS in the upper quartile for the Pharmaceuticals industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

ATR vs. ZTS: A comparison of their Operating Profit Margin (TTM) against their respective Containers & Packaging and Pharmaceuticals industry benchmarks.

Profitability at a Glance

SymbolATRZTS
Return on Equity (TTM)15.28%53.21%
Return on Assets (TTM)8.49%18.27%
Net Profit Margin (TTM)10.84%27.83%
Operating Profit Margin (TTM)14.30%35.35%
Gross Profit Margin (TTM)38.32%71.50%

Financial Strength

Current Ratio (MRQ)

ATR

1.21

Containers & Packaging Industry

Max
2.13
Q3
1.57
Median
1.27
Q1
1.13
Min
0.58

ATR’s Current Ratio of 1.21 aligns with the median group of the Containers & Packaging industry, indicating that its short-term liquidity is in line with its sector peers.

ZTS

1.76

Pharmaceuticals Industry

Max
4.49
Q3
2.77
Median
1.74
Q1
1.26
Min
0.11

ZTS’s Current Ratio of 1.76 aligns with the median group of the Pharmaceuticals industry, indicating that its short-term liquidity is in line with its sector peers.

ATR vs. ZTS: A comparison of their Current Ratio (MRQ) against their respective Containers & Packaging and Pharmaceuticals industry benchmarks.

Debt-to-Equity Ratio (MRQ)

ATR

0.40

Containers & Packaging Industry

Max
4.50
Q3
2.23
Median
1.22
Q1
0.54
Min
0.23

Falling into the lower quartile for the Containers & Packaging industry, ATR’s Debt-to-Equity Ratio of 0.40 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.

ZTS

1.32

Pharmaceuticals Industry

Max
2.44
Q3
1.07
Median
0.42
Q1
0.11
Min
0.00

ZTS’s leverage is in the upper quartile of the Pharmaceuticals industry, with a Debt-to-Equity Ratio of 1.32. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

ATR vs. ZTS: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Containers & Packaging and Pharmaceuticals industry benchmarks.

Interest Coverage Ratio (TTM)

ATR

16.66

Containers & Packaging Industry

Max
13.16
Q3
8.10
Median
3.61
Q1
2.94
Min
1.06

With an Interest Coverage Ratio of 16.66, ATR demonstrates a superior capacity to service its debt, placing it well above the typical range for the Containers & Packaging industry. This stems from either robust earnings or a conservative debt load.

ZTS

15.44

Pharmaceuticals Industry

Max
103.95
Q3
44.18
Median
9.83
Q1
2.82
Min
-42.71

ZTS’s Interest Coverage Ratio of 15.44 is positioned comfortably within the norm for the Pharmaceuticals industry, indicating a standard and healthy capacity to cover its interest payments.

ATR vs. ZTS: A comparison of their Interest Coverage Ratio (TTM) against their respective Containers & Packaging and Pharmaceuticals industry benchmarks.

Financial Strength at a Glance

SymbolATRZTS
Current Ratio (MRQ)1.211.76
Quick Ratio (MRQ)0.831.04
Debt-to-Equity Ratio (MRQ)0.401.32
Interest Coverage Ratio (TTM)16.6615.44

Growth

Revenue Growth

ATR vs. ZTS: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

ATR vs. ZTS: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

ATR

1.30%

Containers & Packaging Industry

Max
7.37%
Q3
4.07%
Median
3.33%
Q1
1.72%
Min
0.00%

ATR’s Dividend Yield of 1.30% is in the lower quartile for the Containers & Packaging industry. This suggests the company’s strategy likely favors retaining earnings for growth over providing a high dividend income.

ZTS

1.24%

Pharmaceuticals Industry

Max
6.98%
Q3
3.32%
Median
2.13%
Q1
0.14%
Min
0.00%

ZTS’s Dividend Yield of 1.24% is consistent with its peers in the Pharmaceuticals industry, providing a dividend return that is standard for its sector.

ATR vs. ZTS: A comparison of their Dividend Yield (TTM) against their respective Containers & Packaging and Pharmaceuticals industry benchmarks.

Dividend Payout Ratio (TTM)

ATR

30.51%

Containers & Packaging Industry

Max
221.20%
Q3
119.52%
Median
58.05%
Q1
28.91%
Min
0.00%

ATR’s Dividend Payout Ratio of 30.51% is within the typical range for the Containers & Packaging industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

ZTS

32.08%

Pharmaceuticals Industry

Max
165.20%
Q3
90.59%
Median
49.13%
Q1
28.91%
Min
0.00%

ZTS’s Dividend Payout Ratio of 32.08% is within the typical range for the Pharmaceuticals industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

ATR vs. ZTS: A comparison of their Dividend Payout Ratio (TTM) against their respective Containers & Packaging and Pharmaceuticals industry benchmarks.

Dividend at a Glance

SymbolATRZTS
Dividend Yield (TTM)1.30%1.24%
Dividend Payout Ratio (TTM)30.51%32.08%

Valuation

Price-to-Earnings Ratio (TTM)

ATR

23.49

Containers & Packaging Industry

Max
35.98
Q3
27.87
Median
16.15
Q1
14.38
Min
8.20

ATR’s P/E Ratio of 23.49 is within the middle range for the Containers & Packaging industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

ZTS

25.93

Pharmaceuticals Industry

Max
42.51
Q3
26.88
Median
19.11
Q1
15.12
Min
0.00

ZTS’s P/E Ratio of 25.93 is within the middle range for the Pharmaceuticals industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

ATR vs. ZTS: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Containers & Packaging and Pharmaceuticals industry benchmarks.

Price-to-Sales Ratio (TTM)

ATR

2.55

Containers & Packaging Industry

Max
2.91
Q3
1.67
Median
0.83
Q1
0.64
Min
0.30

ATR’s P/S Ratio of 2.55 is in the upper echelon for the Containers & Packaging industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

ZTS

7.22

Pharmaceuticals Industry

Max
7.55
Q3
4.54
Median
2.11
Q1
1.52
Min
0.00

ZTS’s P/S Ratio of 7.22 is in the upper echelon for the Pharmaceuticals industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

ATR vs. ZTS: A comparison of their Price-to-Sales Ratio (TTM) against their respective Containers & Packaging and Pharmaceuticals industry benchmarks.

Price-to-Book Ratio (MRQ)

ATR

3.83

Containers & Packaging Industry

Max
5.28
Q3
3.30
Median
2.35
Q1
1.57
Min
0.89

ATR’s P/B Ratio of 3.83 is in the upper tier for the Containers & Packaging industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

ZTS

13.95

Pharmaceuticals Industry

Max
9.78
Q3
4.96
Median
2.23
Q1
1.46
Min
0.60

At 13.95, ZTS’s P/B Ratio is at an extreme premium to the Pharmaceuticals industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

ATR vs. ZTS: A comparison of their Price-to-Book Ratio (MRQ) against their respective Containers & Packaging and Pharmaceuticals industry benchmarks.

Valuation at a Glance

SymbolATRZTS
Price-to-Earnings Ratio (TTM)23.4925.93
Price-to-Sales Ratio (TTM)2.557.22
Price-to-Book Ratio (MRQ)3.8313.95
Price-to-Free Cash Flow Ratio (TTM)26.9230.52